1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Digital Breast Tomosynthesis Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Digital Breast Tomosynthesis by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Digital Breast Tomosynthesis by Country/Region, 2020, 2024 & 2031
2.2 Digital Breast Tomosynthesis Segment by Type
2.2.1 Stand-alone DBT equipment
2.2.2 Integrated
2.3 Digital Breast Tomosynthesis Sales by Type
2.3.1 Global Digital Breast Tomosynthesis Sales Market Share by Type (2020-2025)
2.3.2 Global Digital Breast Tomosynthesis Revenue and Market Share by Type (2020-2025)
2.3.3 Global Digital Breast Tomosynthesis Sale Price by Type (2020-2025)
2.4 Digital Breast Tomosynthesis Segment by Application
2.4.1 Diagnostic Centers
2.4.2 Hospitals
2.4.3 Other
2.5 Digital Breast Tomosynthesis Sales by Application
2.5.1 Global Digital Breast Tomosynthesis Sale Market Share by Application (2020-2025)
2.5.2 Global Digital Breast Tomosynthesis Revenue and Market Share by Application (2020-2025)
2.5.3 Global Digital Breast Tomosynthesis Sale Price by Application (2020-2025)
3 Global Digital Breast Tomosynthesis by Company
3.1 Global Digital Breast Tomosynthesis Breakdown Data by Company
3.1.1 Global Digital Breast Tomosynthesis Annual Sales by Company (2020-2025)
3.1.2 Global Digital Breast Tomosynthesis Sales Market Share by Company (2020-2025)
3.2 Global Digital Breast Tomosynthesis Annual Revenue by Company (2020-2025)
3.2.1 Global Digital Breast Tomosynthesis Revenue by Company (2020-2025)
3.2.2 Global Digital Breast Tomosynthesis Revenue Market Share by Company (2020-2025)
3.3 Global Digital Breast Tomosynthesis Sale Price by Company
3.4 Key Manufacturers Digital Breast Tomosynthesis Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Digital Breast Tomosynthesis Product Location Distribution
3.4.2 Players Digital Breast Tomosynthesis Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2025)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Digital Breast Tomosynthesis by Geographic Region
4.1 World Historic Digital Breast Tomosynthesis Market Size by Geographic Region (2020-2025)
4.1.1 Global Digital Breast Tomosynthesis Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Digital Breast Tomosynthesis Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Digital Breast Tomosynthesis Market Size by Country/Region (2020-2025)
4.2.1 Global Digital Breast Tomosynthesis Annual Sales by Country/Region (2020-2025)
4.2.2 Global Digital Breast Tomosynthesis Annual Revenue by Country/Region (2020-2025)
4.3 Americas Digital Breast Tomosynthesis Sales Growth
4.4 APAC Digital Breast Tomosynthesis Sales Growth
4.5 Europe Digital Breast Tomosynthesis Sales Growth
4.6 Middle East & Africa Digital Breast Tomosynthesis Sales Growth
5 Americas
5.1 Americas Digital Breast Tomosynthesis Sales by Country
5.1.1 Americas Digital Breast Tomosynthesis Sales by Country (2020-2025)
5.1.2 Americas Digital Breast Tomosynthesis Revenue by Country (2020-2025)
5.2 Americas Digital Breast Tomosynthesis Sales by Type
5.3 Americas Digital Breast Tomosynthesis Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Digital Breast Tomosynthesis Sales by Region
6.1.1 APAC Digital Breast Tomosynthesis Sales by Region (2020-2025)
6.1.2 APAC Digital Breast Tomosynthesis Revenue by Region (2020-2025)
6.2 APAC Digital Breast Tomosynthesis Sales by Type
6.3 APAC Digital Breast Tomosynthesis Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Digital Breast Tomosynthesis by Country
7.1.1 Europe Digital Breast Tomosynthesis Sales by Country (2020-2025)
7.1.2 Europe Digital Breast Tomosynthesis Revenue by Country (2020-2025)
7.2 Europe Digital Breast Tomosynthesis Sales by Type
7.3 Europe Digital Breast Tomosynthesis Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Digital Breast Tomosynthesis by Country
8.1.1 Middle East & Africa Digital Breast Tomosynthesis Sales by Country (2020-2025)
8.1.2 Middle East & Africa Digital Breast Tomosynthesis Revenue by Country (2020-2025)
8.2 Middle East & Africa Digital Breast Tomosynthesis Sales by Type
8.3 Middle East & Africa Digital Breast Tomosynthesis Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Digital Breast Tomosynthesis
10.3 Manufacturing Process Analysis of Digital Breast Tomosynthesis
10.4 Industry Chain Structure of Digital Breast Tomosynthesis
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Digital Breast Tomosynthesis Distributors
11.3 Digital Breast Tomosynthesis Customer
12 World Forecast Review for Digital Breast Tomosynthesis by Geographic Region
12.1 Global Digital Breast Tomosynthesis Market Size Forecast by Region
12.1.1 Global Digital Breast Tomosynthesis Forecast by Region (2026-2031)
12.1.2 Global Digital Breast Tomosynthesis Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Digital Breast Tomosynthesis Forecast by Type
12.7 Global Digital Breast Tomosynthesis Forecast by Application
13 Key Players Analysis
13.1 Siemens
13.1.1 Siemens Company Information
13.1.2 Siemens Digital Breast Tomosynthesis Product Portfolios and Specifications
13.1.3 Siemens Digital Breast Tomosynthesis Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Siemens Main Business Overview
13.1.5 Siemens Latest Developments
13.2 Philips
13.2.1 Philips Company Information
13.2.2 Philips Digital Breast Tomosynthesis Product Portfolios and Specifications
13.2.3 Philips Digital Breast Tomosynthesis Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Philips Main Business Overview
13.2.5 Philips Latest Developments
13.3 Hologic
13.3.1 Hologic Company Information
13.3.2 Hologic Digital Breast Tomosynthesis Product Portfolios and Specifications
13.3.3 Hologic Digital Breast Tomosynthesis Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Hologic Main Business Overview
13.3.5 Hologic Latest Developments
13.4 GE Healthcare
13.4.1 GE Healthcare Company Information
13.4.2 GE Healthcare Digital Breast Tomosynthesis Product Portfolios and Specifications
13.4.3 GE Healthcare Digital Breast Tomosynthesis Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 GE Healthcare Main Business Overview
13.4.5 GE Healthcare Latest Developments
13.5 Canon Medical Systems
13.5.1 Canon Medical Systems Company Information
13.5.2 Canon Medical Systems Digital Breast Tomosynthesis Product Portfolios and Specifications
13.5.3 Canon Medical Systems Digital Breast Tomosynthesis Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Canon Medical Systems Main Business Overview
13.5.5 Canon Medical Systems Latest Developments
13.6 Perlong Medical
13.6.1 Perlong Medical Company Information
13.6.2 Perlong Medical Digital Breast Tomosynthesis Product Portfolios and Specifications
13.6.3 Perlong Medical Digital Breast Tomosynthesis Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Perlong Medical Main Business Overview
13.6.5 Perlong Medical Latest Developments
13.7 ANKE
13.7.1 ANKE Company Information
13.7.2 ANKE Digital Breast Tomosynthesis Product Portfolios and Specifications
13.7.3 ANKE Digital Breast Tomosynthesis Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 ANKE Main Business Overview
13.7.5 ANKE Latest Developments
13.8 Angell
13.8.1 Angell Company Information
13.8.2 Angell Digital Breast Tomosynthesis Product Portfolios and Specifications
13.8.3 Angell Digital Breast Tomosynthesis Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Angell Main Business Overview
13.8.5 Angell Latest Developments
13.9 Sinomdt
13.9.1 Sinomdt Company Information
13.9.2 Sinomdt Digital Breast Tomosynthesis Product Portfolios and Specifications
13.9.3 Sinomdt Digital Breast Tomosynthesis Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Sinomdt Main Business Overview
13.9.5 Sinomdt Latest Developments
13.10 Macroo
13.10.1 Macroo Company Information
13.10.2 Macroo Digital Breast Tomosynthesis Product Portfolios and Specifications
13.10.3 Macroo Digital Breast Tomosynthesis Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Macroo Main Business Overview
13.10.5 Macroo Latest Developments
13.11 Orich Medical Equipment
13.11.1 Orich Medical Equipment Company Information
13.11.2 Orich Medical Equipment Digital Breast Tomosynthesis Product Portfolios and Specifications
13.11.3 Orich Medical Equipment Digital Breast Tomosynthesis Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Orich Medical Equipment Main Business Overview
13.11.5 Orich Medical Equipment Latest Developments
13.12 Planmed
13.12.1 Planmed Company Information
13.12.2 Planmed Digital Breast Tomosynthesis Product Portfolios and Specifications
13.12.3 Planmed Digital Breast Tomosynthesis Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Planmed Main Business Overview
13.12.5 Planmed Latest Developments
13.13 Metaltronica
13.13.1 Metaltronica Company Information
13.13.2 Metaltronica Digital Breast Tomosynthesis Product Portfolios and Specifications
13.13.3 Metaltronica Digital Breast Tomosynthesis Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Metaltronica Main Business Overview
13.13.5 Metaltronica Latest Developments
13.14 MEDI-FUTURE
13.14.1 MEDI-FUTURE Company Information
13.14.2 MEDI-FUTURE Digital Breast Tomosynthesis Product Portfolios and Specifications
13.14.3 MEDI-FUTURE Digital Breast Tomosynthesis Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 MEDI-FUTURE Main Business Overview
13.14.5 MEDI-FUTURE Latest Developments
13.15 FUJIFILM
13.15.1 FUJIFILM Company Information
13.15.2 FUJIFILM Digital Breast Tomosynthesis Product Portfolios and Specifications
13.15.3 FUJIFILM Digital Breast Tomosynthesis Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 FUJIFILM Main Business Overview
13.15.5 FUJIFILM Latest Developments
13.16 IMS
13.16.1 IMS Company Information
13.16.2 IMS Digital Breast Tomosynthesis Product Portfolios and Specifications
13.16.3 IMS Digital Breast Tomosynthesis Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 IMS Main Business Overview
13.16.5 IMS Latest Developments
13.17 Genoray
13.17.1 Genoray Company Information
13.17.2 Genoray Digital Breast Tomosynthesis Product Portfolios and Specifications
13.17.3 Genoray Digital Breast Tomosynthesis Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Genoray Main Business Overview
13.17.5 Genoray Latest Developments
14 Research Findings and Conclusion
※参考情報 デジタル式乳房トモシンセシスは、乳房の三次元画像を取得するための先進的な放射線診断技術であります。この技術は、従来のマンモグラフィーに比べて乳がんの早期発見に寄与することが期待されています。それでは、この技術の概念、特徴、種類、用途、関連技術について詳しく説明いたします。 デジタル式乳房トモシンセシスは、乳房を異なる角度から撮影することで、三次元的な画像を生成することができます。この技術では、乳房を挟み込む圧力を加えながら、X線を用いて複数の画像を取得し、それらの画像をコンピュータで再構築することで、3D画像を作成します。これにより、乳房内部の構造をより詳細に観察することが可能となります。 この技術の特徴の一つは、重なり合う組織を明瞭に描出できる点です。従来の2Dマンモグラフィーでは、異常な陰影や腫瘍が脂肪や他の組織と重なる場合、診断が難しくなることがありました。しかし、トモシンセシスは各層を区別して構築された画像を提供するため、異常の発見率が向上するとされています。また、放射線被曝量は従来と比べて少なくなることが期待され、その安全性も向上しています。 デジタル式乳房トモシンセシスには、いくつかの種類があります。基本的には、標準的なトモシンセシス技術が広く使用されており、いくつかの異なる装置やプロトコルが存在します。また、トモシンセシスと従来の2Dマンモグラフィーを組み合わせたハイブリッド技術もあります。このハイブリッド技術により、医師は、胸部の複雑な構造を理解しやすくなるため、診断の精度が向上します。 デジタル式乳房トモシンセシスの用途は主に乳がんの早期発見と診断に関連しています。乳がんの早期発見は治療成績に大きく影響するため、トモシンセシスの導入が進められています。また、この技術は乳がんのスクリーニング検査にも利用され、特にリスクの高い女性に対して積極的に使用されています。さらに、既に乳がんと診断された患者に対する治療効果のモニタリングにも貢献しています。 関連技術としては、人工知能(AI)や機械学習が挙げられます。最近では、画像解析にAIを活用する取り組みが進んでおり、トモシンセシスによって得られたデータをさらに詳細に解析することで、画像診断の精度を高める試みが行われています。AIは、自動的に異常を検出し、医師に結果を通知する機能を持つことができるため、診断プロセスの効率化にも寄与しています。 また、デジタル式乳房トモシンセシスは、従来の方法と比べて患者への負担を軽減することができるため、受診率の向上にもつながっています。乳がんの早期診断においては、検診を受けることが最も重要であり、このような技術の普及は公共の健康に対しても良い影響を与えると考えられています。 さらに、今後の研究においては、トモシンセシスの技術向上に伴い、さらに多様な応用が期待されます。例えば、乳腺組織の質的評価や、異常組織の特定、さらには治療計画の策定においても、新しい可能性が開かれることが予想されます。 このように、デジタル式乳房トモシンセシスは、乳がんスクリーニングと診断の分野において重要な位置を占める技術であり、その特性や使用が拡大しています。今後はさらに洗練された技術の登場や、新たな検査方法の開発が期待されており、患者の健康増進に寄与することが見込まれます。これにより、早期発見・早期治療の実現が進み、乳がんによる死亡率の低下に寄与することとなるでしょう。 |
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/